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Abstract
Mendelian Randomization (MR) is a popular method in epidemiology and genetics
that uses genetic variation as instrumental variables for causal inference. Existing MR
methods usually assume most genetic variants are valid instrumental variables that
identify a common causal effect. There is a general lack of awareness that this effect
homogeneity assumption can be violated when there are multiple causal pathways
involved, even if all the instrumental variables are valid. In this article, we introduce a
latent mixture model MR-PATH that groups instruments that yield similar causal effect
estimates together. We develop a Monte-Carlo EM algorithm to fit this mixture model,
derive approximate confidence intervals for uncertainty quantification, and adopt a
modified Bayesian Information Criterion (BIC) for model selection. We verify the
efficacy of the Monte-Carlo EM algorithm, confidence intervals, and model selection
criterion using numerical simulations. We identify potential mechanistic heterogeneity
when applying our method to estimate the effect of high-density lipoprotein cholesterol
on coronary heart disease and the effect of adiposity on type II diabetes.
Keywords: Causal inference, Instrumental variables, EM algorithm, Monte-Carlo sampling,
HDL cholesterol, Diabetes
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1 Introduction
Mendelian randomization (MR) is a causal inference method that aims to estimate the causal
effect of a modifiable risk exposure on disease outcomes. MR is a special case of instrumental
variable methods that have a long history in statistics and econometrics. The key insight of
MR is that genetic variants, usually in the form of single nucleotide polymorphisms (SNPs),
are naturally randomised during conception and may serve as good instrumental variables for
many epidemiological risk factors (Smith and Ebrahim, 2004; Didelez and Sheehan, 2007).
As a study design, MR has been quickly gaining popularity among epidemiologists because of
its ability to give unbiased causal effect estimates in the presence of unmeasured confounding
and the increasing availability of genome-wide association studies (GWAS) data.
A key assumption of MR is that the genetic instrumental variables can only affect the
outcome variables through the risk exposure under investigation. This is often referred to
as the “exclusion restriction” or “no direct effect” assumption in the instrumental variable
literature. With genetic variants as instruments, this assumption may be violated due to
a genetic phenomenon called “pleiotropy”, meaning a single genotype can affect multiple
seemingly unrelated phenotypes. Recent empirical evidence and genetic theory suggest that
pleiotropy is pervasive for common traits (Boyle et al., 2017; Liu et al., 2019). This has lead
to a burst of development of new statistical methods aiming to make MR studies robust to
different patterns of pleiotropy (Bowden et al., 2015; Kang et al., 2016; Zhao et al., 2020;
Verbanck et al., 2018; Burgess et al., 2020; Qi and Chatterjee, 2019).
To our knowledge, the vast majority of these robust MR methods still rely on the “effect
homogeneity” assumption that the risk exposure has the same causal effect for every indi-
vidual. This assumption usually follows from assuming a linear structural equation model
commonly used in the instrumental variable literature (Anderson and Rubin, 1949; Bow-
den et al., 2017). However, this key assumption may be unrealistic when we use MR to
study complex biological systems involving multiple mechanisms, as demonstrated in the
next example.
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1.1 Motivating example: The effect of HDL cholesterol on coro-
nary heart disease
The statistical model we develop in this article is motivated by a real world problem. Over
the last few decades, there has been a heated debate in cardiology on the role of high-
density lipoproteins (HDL) in coronary heart disease (CHD) (Rader and Hovingh, 2014;
Davey Smith and Phillips, 2020). Numerous observational studies have found a consistent
inverse association between HDL cholesterol (HDL-C, amount of cholesterol carried in HDL
particles) and CHD, lending support to a theory that HDL plays a causally protective role
in atherogenesis (formation of fatty deposits in the arteries) through a biological mechanism
called reverse cholesterol transport (HDL particles remove excessive cholesterol in peripheral
tissues). This led to a once widely held belief among healthcare professionals and the general
public that HDL particles are the “good cholesterol”, as opposed to low-density lipoproteins
(LDL) which are thought to be the “bad cholesterol”.
However, the HDL hypothesis has received close scrutiny after several promising clinical
trials raising HDL cholesterol through the CETP inhibitors demonstrated no or only modest
cardiovascular benefit (Armitage et al., 2019). Moreover, a prominent MR study further
challenged the presumption that raising HDL-C will uniformly translate into reductions in
risk of CHD (Voight et al., 2012). Although there are lots of SNPs associated with HDL-C,
many of them are also associated with LDL cholesterol and/or triglycerdes. Due to this
reason, Voight et al. (2012) based their main argument on a SNP in the LIPG gene that
does not exhibit significant association with LDL cholesterol and triglycerides, even though
other genetic instruments showed varied associations with risk of CHD. This shows that
pleiotropy, arising from the multiple mechanisms involved in the synthesis and regulation of
blood lipids, poses a major challenge for using MR methods to study HDL.
Using some of the latest large-scale GWAS datasets for HDL-C and CHD, we created
a dataset to visualize and analyze the heterogeneity among potential genetic instruments
for HDL (Figure 1). Each point in this plot shows the reported associations of a SNP with
HDL-C and CHD in the GWAS (with standard error bars). Figure 1a shows a straight line
across the origin whose slope is obtained using a previous method called MR-RAPS that
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(b) Proposed mixture model.
Figure 1: Scatterplot of HDL-CAD data. Left: Line/shaded region represents the causal
effect estimate ± one standard error from MR-RAPS. Right: Lines/shaded regions represent
heterogeneous causal effect estimates ± one standard deviation from our proposed mixture
model.
assumes a homogeneous effect of HDL-C on CHD (Zhao et al., 2020). If this assumption
holds, the slope in Figure 1a can be interpreted as the causal effect of HDL-C on CHD.
However, it is clear from Figure 1a that the slope estimated by MR-RAPS provides a poor
fit to the scatterplot.
In this paper, we propose to fit this dataset using an alternative model where the SNPs
have individual slopes that are drawn from a mixture distribution. This would be the case if
there are several biological mechanisms involved in regulating HDL-C; see Section 3. In this
example, MR-PATH selects two clusters (shown in Figure 1b) which provides a much better
fit to the data. See Section 7 for more detail about the data collection for this example and
the results of our model.
1.2 Related work and our contributions
There have been several attempts to develop MR methods that allow for heterogeneous
causal effects. We are also not the first to use mixture models for MR. The contamination
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mixture method proposed by Burgess et al. (2020) uses a two-component mixture model
to distinguish between valid and invalid instruments. Similarly, the MR-Mix method (Qi
and Chatterjee, 2019) uses a four-component mixture model to identify one group of valid
instruments and three groups of invalid instruments which have either direct effects on both
the exposure and outcome, direct effects on the outcome but no effect on the exposure,
or no effect on both the exposure and outcome. However, the purpose of using mixture
models in these approaches is not to identify different mechanisms but rather to provide a
realistic model for the invalid instruments. In particular, they assume that the majority of
the instruments are valid and indicate an identical causal effect.
The only methods we are aware of that does not assume effect homogeneity and attempts
to distinguish causal mechanisms are GRAPPLE (Wang et al., 2020), MR-Clust (Foley
et al., 2019) and BESIDE-MR (Shapland et al., 2020). GRAPPLE proposes to use the local
maximums of a robustified profile likelihood function (Zhao et al., 2020) to discover multiple
mechanisms. However, GRAPPLE is only a visualization tool and does not attempt to
explicitly model the different mechanisms. MR-Clust works by constructing a mixture model
based on SNP-specific Wald estimators. Similar to our proposed method, MR-Clust does not
make further assumptions about the number of clusters and the structure of each cluster.
However, a major limitation of MR-Clust is its assumption that the SNP-specific Wald
estimates are normally distributed, which is a poor approximation for weak instruments.
BESIDE-MR is another related method that uses Bayesian model averaging. Although
BESIDE-MR is initially motivated by averaging over the uncertainty in selecting the valid
instruments, it can also be extended to allow for multiple clusters of instruments indicating
different causal effects. However, BESIDE-MR is not a full likelihood approach because it
uses the profile likelihood derived in Zhao et al. (2020) to eliminate the nuisance parameters
related to the SNP-exposure effects.
Our paper makes two main contributions to this fast growing literature. First, there is a
general lack of awareness that MR can be used to discover multiple biological mechanisms,
partly due to the wide usage of the broad terminology “effect heterogeneity” to refer to several
different phenomena—invalid instrument due to pleiotropy, effect modification/moderation
by a covariate, and effect heterogeneity due to different causal mechanisms. In this article
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we introduce the concept of mechanistic heterogeneity for the last phenomenon and show
that it can occur even if all the instruments are valid.
Our second contribution is a transparent mixture model, which we call MR-PATH, to
capture the mechanistic heterogeneity and the adaptation of a Monte Carlo EM algorithm
to fit this model. Because our model is based on the SNP-exposure and SNP-outcome
associations, it does not require the individual instruments to be strong. Since our Monte
Carlo EM algorithm maximizes the full likelihood function for the latent mixture model, it
has all the benefits of likelihood-based inference.
The rest of the paper is organized as follows. In section 2, we give a brief review of
the standard assumptions in MR. In section 3, we introduce the concept of mechanistic
heterogeneity and in section 4 we propose to model it with MR-PATH. In section 5, we
describe an Monte Carlo EM algorithm to fit MR-PATH and discuss the relevant statistical
inference and model selection procedures. We then study the performance of our Monte
Carlo EM algorithm with two simulation studies in section 6 and apply it to two real data
datasets (including the HDL-CHD example above) in section 7. We conclude the paper with
some ending remarks in section 8.
2 MR as an instrumental variables method
The goal of MR is to estimate the causal effect of a risk exposure variable (X) on a dis-
ease outcome variable (Y) with summary-level data from GWAS. In particular, we may be
interested in the causal effect of HDL cholesterol (X) on the risk of coronary heart disease
(Y). Regression analyses between X and Y are typically biased by unobserved confounding
variables U . MR uses p genetic variants Z1, . . . , Zp as instrumental variables to obtain an
unbiased causal effect estimate of X on Y. A genetic variant Z is said to be a valid instrument
for estimating the causal effect of X on Y if it satisfies the following assumptions:
Assumption 2.1 (Relevance) It is associated with the risk exposure, i.e. Corr(Z,X) 6= 0.
Assumption 2.2 (Independence) It must be independent of any unmeasured confounders
that are associated with both the exposure and outcome, i.e. Z |= U .
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Figure 2: A directed acyclic graph (DAG) illustrating the core assumptions for a valid
instrument.
Assumption 2.3 (Exclusion restriction) It affects the outcome only through the risk ex-
posure, i.e. Z |= Y | X.
Figure 2 provides a graphical representation of these assumptions. The independence
assumption is guaranteed by Mendel’s law of random assortment of genes. The relevance
assumption is justified if genetic variants are chosen to be genome-wide significant. Among
the three assumptions, the ER assumption is the most problematic due to pleiotropy. As-
sessment of the IV assumptions and sensitivity analysis in MR are discussed by Burgess
et al. (2017). In the MR literature, it is common to assume the following linear structural
equation model for the exposure and outcome variables (Bowden et al., 2017):
X =
p∑
i=1
θXiZi + ηXU + EX , (1)
Y = βX +
p∑
i=1
αiZi + ηYU + EY , (2)
where ηX and ηY are confounding effects and EX and EY are random noise terms acting
on X and Y respectively. The causal effect between X and Y is given by the parameter
β. The true marginal association between X and Zi is given by θXi . The direct effect
of Zi on Y is given by αi. Assumption 2.1 implies θXi 6= 0 and assumption 2.2 implies
Z1, . . . , Zp |= U,EX , EY . Under this model, the exclusion restriction assumption is violated
if αi 6= 0. In particular, this can occur if Zi affects Y through a mechanism unrelated to X
(see fig. 3a for illustration). Plugging eq. (1) into eq. (2), we obtain
Y =
p∑
i=1
(
βθXi + αi
)
Zi + (ηX + ηY )U + (EX + EY ) =
p∑
i=1
θYiZi + E
′
Y , (3)
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where θYi = βθXi + αi gives the true marginal association between Y and Zi and E
′
Y is a
random noise term that is independent of Zi. In summary-data MR, we usually observe
the estimated SNP-exposure effect θˆXi , with standard error σXi , and the estimated SNP-
outcome effect θˆYi , with standard error σYi , for SNP i = 1, . . . , p. These estimated effects
are typically computed from two different samples using linear or logistic regression. If we
assume the genetic variants Z1, . . . , Zp satisfy the exclusion restriction assumption, in other
words α1 = · · · = αp = 0, then the causal effect parameter β can be estimated consistently
with the inverse-variance-weighted estimator Burgess et al. (2013). A more robust approach
is to perform error-in-variables regression of θˆYi on θˆXi (Zhao et al., 2020). We adopt this
approach in MR-PATH. If the exclusion restriction assumption is violated for some SNPs,
then the causal effect parameter β cannot be identified without further assumptions on αi.
For example, Zhao et al. (2020) assumes that αi ∼ N(0, τ 2) for most genetic variants so that
the direct effects are balanced out.
3 Mechanistic heterogeneity in MR
Instruments Z Pathway M Effect of M on X Effect of M on Y Wald estimand
Scenario 1
Z1,1, . . . , Z1,p1 M1 θ1 θ1β β
Z2,1, . . . , Z2,p2 M2 θ2 θ2β + α2 β + α2/θ2
Z3,1, . . . , Z3,p3 M3 θ3 θ3β + α3 β + α3/θ3
Scenario 2
Z1,1, . . . , Z1,p1 M1 θ1 θ1β1 β1
Z2,1, . . . , Z2,p2 M2 θ2 θ2β2 β2
Z3,1, . . . , Z3,p3 M3 θ3 θ3β3 β3
Table 1: Ratio estimands using different instruments in the two scenarios in Figure 3. Di-
rected acyclic graphs in Figure 3 are interpreted as linear structural equation models.
The assumption that the direct effect αi is iid normally distributed does not take into
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Figure 3: Two scenarios of mechanistic heterogeneity.
account the possibility that genetic variation often affects phenotypic traits through separate
biological pathways. In this section we show that such behaviour may lead to a clustering
phenomenon where SNPs belonging to the same pathway would indicate similar causal effects
in an MR analysis. This is what we call “mechanistic heterogeneity” in MR.
3.1 Two origins of mechanistic heterogeneity
Consider Figure 3 which contains two scenarios of mechanistic heterogeneity that motivate
the latent mixture model. In both scenarios, genetic variants are grouped into three biological
pathways, M1, M2, and M3, that affect the exposure X and outcome Y differently. In the
first scenario (Figure 3a), all three pathways affect X in the same way but have different
direct effects on Y . In particular, the first pathway M1 does not have any direct effect on
Y not mediated by X, so the instruments Z1,1, . . . , Z1,p1 associated with it are all valid IVs.
In the second scenario in Figure 3b, the three pathways affect different components of the
exposure X which also have different causal effects on the outcome Y .
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If we interpret the diagrams in Figure 3 as linear structural equations (like Figure 2 for (1)
and (2)), we can derive the so-called Wald estimand (ratio of θY and θX) for each instrument
(Table 1). In both scenarios in Figure 3, genetic instruments on the same pathway have
the same Wald estimand θY /θX , while instruments across different pathways generally have
different estimands.
Therefore, we may reach completely different conclusions when using instruments on
different pathways in the MR analysis. In reality, mechanistic heterogeneity can be more
complicated than the basic scenarios in Figure 3. For example, another pathway can affect
some components of X and also have direct effect on Y . It is also worthwhile to point
out that mechanistic heterogeneity can arise even when all the IVs are perfectly valid; an
example is Scenario 2 in Figure 3.
3.2 Relationship to local average treatment effect
The above introduction of mechanistic heterogeneity is entirely based on linear structural
equation models. Next we show that the same clustering phenomenon can also happen
when there is nonlinearity. Consider the causal diagram in Figure 3a without the M2 → Y
and M3 → Y edges, so all the instruments Z1,1, . . . , Z3,p3 are valid (satisfy Assumptions 2.1
to 2.3). Suppose the variables satisfy the nonparametric structural equation model (NPSEM)
with independent errors (Pearl, 2009) according to Figure 3a, so the counterfactuals of
Mk, k = 1, 2, 3, X, and Y can be defined using the NPSEM. For example, we use Y (X = 1) to
denote the counterfactual outcome under the intervention X = 1. To simplify our illustration
below, we assume Z1,1, . . . , Z3,p3 , M1,M2,M3, and X are all binary variables.
It is well known that if the instrument Zk,j is valid and the counterfactuals of the exposure
X satisfies the monotonicity assumption X(Zk,j = 1) ≥ X(Zk,j = 0), the Wald estimand for
instrument Zk,j is equal to the so-called local average treatment effect, E[Y (X = 1)−Y (X =
0) | X(Zk,j = 1) > X(Zk,j = 0)] (Angrist et al., 1996). Notice that this interpretation of the
IV analysis does not require linearity of the structural equation model. Suppose we further
assume the effect of Z on M is monotone, Mk(Zk,j = 1) ≥ Mk(Zk,j = 0), and the effect of
M on X is monotone, X(Mk = 1) ≥ X(Mk = 0). Using the properties of counterfactuals
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and the fact in Figure 3a that Zk,j affects X entirely through Mk, we get
X(Zk,j = z) = X(Zk,j = z,Mk = Mk(Zk,j = z)) = X(Mk = Mk(Zk,j = z)).
Thus, using the assumption that X and Mk are binary,
E
[
Y (X = 1)− Y (X = 0) | X(Zk,j = 1) > X(Zk,j = 0)
]
=E
[
Y (X = 1)− Y (X = 0) | X(Mk = Mk(Zk,j = 1)) > X(Mk = Mk(Zk,j = 0))]
=E
[
Y (X = 1)− Y (X = 0) | X(Mk = 1) > X(Mk = 0),Mk(Zk,j = 1) > Mk(Zk,j = 0)
]
=E
[
Y (X = 1)− Y (X = 0) | X(Mk = 1) > X(Mk = 0)
]
.
(4)
The last equality above uses
{Mk(Zk,j = 0),Mk(Zk,j = 1)} |= {X(Mk = 0), X(Mk = 1), Y (X = 0), Y (X = 1)}.
This counterfactual independence follows from expressing the counterfactuals using the
NPSEM and the assumption that the different structural equations have independent er-
rors.
The significance of (4) is that, if the counterfactuals of M and X satisfy the monotonicity
assumption, the local average treatment effect corresponding to Zk,j only depends on the
mechanism index k. This shows that the clustering of the Wald esimand in Section 3.1 not
only occurs in linear structural equation models but also in certain nonlinear models. These
examples demonstrate the importance of identifying mechanistic heterogeneity to correctly
interpret MR studies.
4 MR-PATH: A latent mixture model for mechanistic
heterogeneity
Motivated by the observations in the previous section, we propose a latent mixture model
to discover mechanistic heterogeneity using summary GWAS data. In essence, this model
assumes that each genetic variant has a specific causal effect and the genetic variants on
the same biological pathway have similar variant-specific causal effects and form clusters.
The mean of each cluster corresponds to the Wald estimand of that pathway (last column
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in table 1). These assumptions, along with standard assumptions for summary-data MR
literature, are introduced below.
Assumption 4.1 (Error-in-variables regression) The observed instrument-exposure and
instrument-outcome associations are distributed asθˆXi
θˆYi
 indep.∼ N(
 θXi
βiθXi
 ,
σ2Xi 0
0 σ2Yi
), i = 1, . . . , p, (5)
where σXi, σYi are (fixed) measurement errors.
In this assumption, the variant-specific causal effects are given by βi. The normality
assumption is justified because θˆXi and θˆYi are typically linear (or logistic) regression coef-
ficients which are computed in GWAS with a large sample size. Independence between θˆXi
and θˆYi for each SNP is justified if they are from GWAS conducted with non-overlapping
samples. Independence of the estimated effects across different SNPs is a reasonable as-
sumption if we select SNPs that are uncorrelated by using linkage disequilibrium clumping.
Although independence between SNPs does not imply the estimated effects are uncorrelated,
the correlation between the estimated effects are typically negligible (Zhao et al., 2020).
Assumption 4.2 (Mixture model for mechanistic heterogeneity)
Zi ∼ Categorical (pi1, . . . , piK), (6)
βi|Zi = k ∼ N(µk, σ2k), k = 1, . . . , K. (7)
We assume a Gaussian mixture model for the variant-specific (latent) causal effects βi to
probabilistically cluster genetic variants with similar causal effects. An indicator variable for
cluster membership of SNP i is given by Zi. We can compute the posterior distribution of Zi
and βi to summarize our knowledge of these variant-specific latent variables based on data
(see section 5.4). The K clusters represent different causal mechanisms where the cluster
means µk, for k = 1, . . . , K, identify the average causal effects for each mechanism. The
cluster proportions pik give us the proportion of genetic variants associated with each mecha-
nism. The cluster variances σ2k quantify uncertainty within each mechanism. Therefore, the
parameters of interest in MR-PATH are given by ϕ = {pik, µk, σ2k : k = 1, . . . , K}. The num-
ber of clusters K is unknown but can be chosen based on heuristics and domain knowledge
or estimated from data—see section 5.5 for a model selection criterion for choosing K.
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5 Statistical inference for MR-PATH
In order to fit MR-PATH to gain insight into mechanistic heterogeneity, we proceed by
discussing three inference procedures. First, we describe our implementation of the EM
algorithm for obtaining a maximum likelihood estimate of ϕ and point out the challenges and
our solutions for the expectation step. Second, we discuss approximate confidence intervals
for ϕ obtained by computing and inverting the observed information matrix. Lastly, we
go into how K can be selected from data using a modified Bayesian Information criterion
(BIC). Let D = {(θˆXi , σXi , θˆYi , σYi) : i = 1, . . . , p} denote the observed data and let Θ =
{(θXi , βi, Zi) : i = 1, . . . , p} denote the set of latent variables.
5.1 Overview of the EM Algorithm
The Expectation-Maximization (EM) algorithm is an iterative procedure commonly used
to perform maximum likelihood estimation in latent variable models. To define the EM
algorithm for MR-PATH, we derive two important model quantities: the complete-data log
likelihood and the conditional posterior of the latent variables Θ, given parameters ϕ. The
latter is used to compute the Q-function in the expectation step. Let φ(·;µ, σ2) denote the
density of N(µ, σ2). We make the additional model assumption that θˆXi ∼ N(mx, λ2x). It
follows that the complete-data log likelihood for MR-PATH is given by
l(ϕ; Θ) :=
p∑
i=1
li(ϕ; θXi , βi, Zi), (8)
where
li(ϕ; θXi , βi, Zi) ∝ log φ(θXi ;mx, λ2x) +
K∑
k=1
Zik
[
log pik + log φ(βi;µk, σ
2
k)
]
(9)
and Zik = 1, if Zi = k, and 0 otherwise. The conditional posterior of the latent variables
given ϕ can be decomposed as
P (Θ|D, ϕ) :=
p∏
i=1
P (βi, Zi, θXi |θˆXi , θˆYi , ϕ)
=
p∏
i=1
K∏
k=1
[
P (Zi = k|βi, ϕ)
]ZikP (βi|θXi , θˆYi , ϕ)P (θXi|θˆXi , θˆYi , ϕ), (10)
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where P (Zi = k|βi, ϕ) and P (βi|θXi , θˆYi , ϕ) are available in closed-form and are given by
P (Zi = k|βi, ϕ) = pikφ(βi;µk, σ
2
k)∑K
j=1 pijφ(βi;µj, σ
2
j )
, (11)
P (βi|θXi , θˆYi , ϕ) =
K∑
k=1
pikφ(βi; µ˜ik, σ˜
2
ik); (12)
where
σ˜2ik =
( 1
σ2k
+
θ2Xi
σ2Yi
)−1
, µ˜ik = σ˜
2
ik
( θˆYiθXi
σ2Yi
+
µk
σ2k
)
.
Unfortunately, instead of having an analytical solution, the probability density P (θXi|θˆXi , θˆYi , ϕ)
is known only up to a multiplicative constant given by
P (θXi |θˆXi , θˆYi , ϕ) ∝ P (θXi |θˆXi , ϕ)P (θˆYi |θXi , ϕ)
= φ(θXi ;mXi , λ
2
Xi
)
K∑
k=1
pikφ(θˆYi ; θXiµk, θ
2
Xi
σ2k + σ
2
Yi
), (13)
where
λ2Xi =
( 1
σ2Xi
+
1
λ2x
)−1
, mXi = λ
2
Xi
( θˆXi
σ2Xi
+
mx
λ2x
)
.
The EM algorithm starts with initial values for the parameter estimates ϕ(0). Each
iteration t = 1, 2, . . . of the EM algorithm consists of an expectation step (E-step) and
a maximization (M-step). The E-step involves computing the Q-function, defined as the
expectation of the complete-data log likelihood with respect to the conditional posterior
of the latent variables given the previous iterations parameter estimates. Specifically, the
E-step can be represented by
Q(ϕ, ϕ(t−1)) = E
[
l(ϕ; Θ)|D, ϕ(t−1)], (14)
where the expectation is taken with respect to P (Θ|D, ϕ). The M-step consists of com-
puting an update of the parameter estimates for the current iteration as the value that
maximizes the Q-function. In other words, the M-step involves
ϕ(t) = arg max
ϕ
Q(ϕ, ϕ(t−1)). (15)
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The EM algorithm guarantees the likelihood is non-decreasing across iterations—ascent
property—and is theoretically guaranteed, under mild regularity conditions, to converge to
a local optimum (Wu, 1983). In practice, a commonly used heuristic for determining the EM
algorithm has converged is when the increase in the Q-function from the previous iteration
is less than a specified threshold. Unfortunately, since P (Θ|D, ϕ) is only known up to a
multiplicative constant, the Q-function for MR-PATH cannot be computed analytically. In
the next section, we discuss our implementation of a variant of the EM algorithm where
the Q-function in the E-step is approximated using Monte-Carlo methods—the Monte-Carlo
EM (MC-EM) algorithm.
5.2 Implementation of the Monte-Carlo EM Algorithm
The MC-EM algorithm allows us to perform maximum likelihood estimation in latent vari-
able models where the Q-function cannot be computed analytically but can be approximated
using Monte-Carlo methods. In section 5.2.1, we describe an importance sampling (IS)
scheme for approximating the Q-function in MR-PATH. The main drawback of the MC-EM
algorithm is that Monte-Carlo error accrued from approximating the Q-function may cause
the algorithm to not converge (Neath, 2013). More precise approximations of the Q-function
are needed as the M-step updates approach a local optimum. Furthermore, the MC-EM algo-
rithm does not satisfy the ascent property of the vanilla EM algorithm. A simple solution to
these issues is to set the number of Monte-Carlo samples used to approximate the Q-function
(MC sample size) to be very large or increase the MC sample size by a deterministic large
amount at each iteration. However, this may not be computationally feasible, thus creating
a trade-off between statistical consistency and computational efficiency. In section 5.2.2, we
discuss an automated data-driven procedure introduced by Caffo et al. (2005) that guaran-
tees the ascent property is satisfied with high probability by assessing Monte-Carlo error at
the end of each iteration and increasing the MC sample size accordingly.
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5.2.1 Monte-Carlo E-step using Importance Sampling
The decomposition of P (Θ|D, ϕ) in eq. (10) suggests that we can obtain importance samples
from P (Θ|D, ϕ) by first drawing samples of {θXi} from an importance (proposal) distribu-
tion. Given importance samples of {θXi}, we can obtain importance samples of {βi} and {Zi}
by directly sampling from
∏p
i=1 P (βi|θXi , θˆXi , ϕ) and
∏p
i=1 P (Zi|βi, ϕ), which are available in
closed form in eq. (11) and eq. (12). Then, we can estimate the Q-function with a sum of the
complete-data log-likelihood evaluated at the samples weighted by the importance weights.
Choosing an importance distribution that yields an efficient sampling procedure is a non-
trivial task that depends on the form of the target distribution (see Tokdar and Kass (2010)
for a review). In our case, the target distribution is
∏p
i=1 P (θXi |θˆXi , θˆYi , ϕ) so a sensible
choice for an importance (proposal) distribution would be
∏p
i=1 P (θXi |θˆXi , ϕ), the posterior
distribution of {θXi} given only {θˆXi} instead of the full data {θˆXi , θˆYi} which has a closed
form given in eq. (13). This choice of importance distribution yields importance weights that
are bounded and have a finite variance.
More precisely, let mt denote the number of desired importance samples at iteration t and
ϕ˜(t−1) denote the MC-EM update from iteration t−1. For each i = 1, . . . , p and j = 1, . . . ,mt,
suppose θjXi ∼ P (θXi |θˆXi , ϕ(t−1)), βji ∼ P (βi|θXi , θˆYi , ϕ(t−1)), and Zji ∼ P (Zi|βi, ϕ(t−1)). From
eq. (13), we have that the unnormalized importance weights are given by
wji = P (θˆYi |θjXi , ϕ˜(t−1)) =
K∑
k=1
p˜i
(t−1)
k φ
(
θˆYi ; θ
j
Xi
µ˜
(t−1)
k , (θ
j
Xi
)2σ˜
2(t−1)
k + σ
2
Yi
)
(16)
for j = 1, . . . ,M . It can be shown that 0 ≤ wji ≤
(
2piσ2Yi
)−1/2
(proof is provided in ap-
pendix A.1). Let w¯ji = w
j
i /
∑mt
j=1w
j
i be the normalized importance weights. The IS estimate
of the Q-function at iteration t is given by
Q˜(ϕ, ϕ˜(t−1);mt) =
p∑
i=1
mt∑
j=1
w¯ji l
j
i (ϕ), (17)
where
lji (ϕ) = li(ϕ; θ
j
Xi
, βji , Z
j
i ),
and li is defined in eq. (9). Consequently, the MC-EM update of the model parameters at
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iteration t approximated with Monte-Carlo sample size mt is given by
ϕ˜(t,mt) = arg max
ϕ
Q˜(ϕ, ϕ˜(t−1);mt).
5.2.2 Ascent-Based Monte-Carlo EM
At the end of each MC-EM iteration, the ascent-based MC-EM algorithm (Caffo et al.,
2005) performs a hypothesis test to determine whether the Q-function has increased from
the previous iteration. If there is not sufficient evidence that suggests the Q-function has
increased, we reject the current iteration’s M-step and repeat the iteration with a larger
MC sample size. In this section, we will describe this procedure concretely for our inference
problem.
Define the change in the Q function at iteration t of MC-EM as
∆Q(ϕ˜(t,mt), ϕ˜(t−1)) := Q(ϕ˜(t,mt), ϕ˜(t−1))−Q(ϕ˜(t−1), ϕ˜(t−1)). (18)
After obtaining ϕ˜(t,mt) in the M-step, we are interested in performing the following hy-
pothesis test at a specified significance level α:
H0 : ∆Q(ϕ˜
(t,mt), ϕ˜(t−1)) = 0, (19)
HA : ∆Q(ϕ˜
(t,mt), ϕ˜(t−1)) > 0.
If we reject H0, then we accept ϕ˜
(t,mt) and move on to the next iteration. If we fail to
reject H0, then we reject ϕ˜
(t,mt) and repeat the current iteration with a larger Monte-Carlo
sample size. The change in the Q function in eq. (18) can be approximated using
∆Q˜(ϕ˜(t,mt), ϕ˜(t−1)) ≈
p∑
i=1
mt∑
j=1
wjiΛ
(t)
ij (20)
where
Λ
(t)
ij = l
j
i (ϕ˜
(t,mt))− lji (ϕ˜(t−1)). (21)
It was shown in Caffo et al. (2005) that under H0,
√
mt∆Q˜(ϕ˜
(t,mt), ϕ˜(t−1)) d→ N(0, η2) (22)
as mt →∞, where σ2 depends on the sampling procedure used. We can obtain an estimate
of η2, ηˆ2, by computing the variance of the importance sampling estimate in eq. (20) (details
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provided in appendix A.2). Therefore, we can reject H0 with approximate significance level
α if
∆Q˜(ϕ˜(t,mt), ϕ˜(t−1))− zα ηˆ
mt
> 0
where zα is the (1−α)th quantile of the standard normal distribution. If we fail to reject H0,
we repeat iteration t with a larger mt until we are able to reject H0. Similarly, a convenient
stopping criterion is obtained by testing
HA : ∆Q(ϕ˜
(t,mt), ϕ˜(t−1)) < 
at a specified significance level γ and threshold . We can reject H0 with approximate
significance level γ and determine MC-EM has converged if
∆Q˜(ϕ˜(t,mt), ϕ˜(t−1)) + zγ
ηˆ
mt
< .
5.3 Approximate Confidence Intervals
To quantify uncertainty of the parameter estimates obtained using the MC-EM algorithm,
we adapt the method in (Louis, 1982) for computing the observed information matrix in the
EM framework. Standard errors, and therefore approximate confidence intervals, can then
be obtained by inverting the observed information matrix. By a result presented in (Louis,
1982), the observed information matrix at a point ϕ∗ can be computed by
I(ϕ∗) =
{
E
[
− ∂
2l(ϕ)
∂ϕ∂ϕT
∣∣∣D, ϕ∗]− E[(∂l(ϕ)
∂ϕ
∂l(ϕ)
∂ϕT
)∣∣∣D, ϕ∗]
+ E
[∂l(ϕ)
∂ϕ
∣∣∣D, ϕ∗]E[∂l(ϕ)
∂ϕT
∣∣∣D, ϕ∗]}∣∣∣
ϕ=ϕ∗
(23)
where the dependence of D, Θ in the log-likelihood have been suppressed for notational
convenience. Let ϕˆ denote the final MC-EM parameter estimate and suppose {θjXi , βji ,
Zji : j = 1, . . . ,M} are now importance samples from P (θXi , βi, Zi|D, ϕˆ) with (normalized)
weights {wji }. The first and third expectations in eq. (23) can be approximated by
E
[
− ∂
2l(ϕ)
∂ϕ∂ϕT
∣∣∣D, ϕ] ≈ p∑
i=1
M∑
j=1
wji
∂2lji (ϕ)
∂ϕ∂ϕT
,
and E
[∂l(ϕ)
∂ϕ
∣∣∣D, ϕ] ≈ p∑
i=1
M∑
j=1
wji
∂lji (ϕ)
∂ϕ
.
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The second expectation in eq. (23) can be approximated by
E
[(∂l(ϕ)
∂ϕ
∂l(ϕ)
∂ϕT
)∣∣∣D, ϕ∗] = p∑
i=1
E
[( ∂
∂ϕ
li(ϕ)
)( ∂
∂ϕ
li(ϕ)
)T]
+ 2
∑
i<n
E
[ ∂
∂ϕ
li(ϕ)
]
E
[ ∂
∂ϕ
ln(ϕ)
]T
≈
p∑
i=1
M∑
j=1
wji
∂lji (ϕ)
∂ϕ
∂lji (ϕ)
∂ϕT
+ 2
∑
i<n
[ M∑
j=1
wji
∂lji (ϕ)
∂ϕ
][ M∑
j=1
wji
∂ljn(ϕ)
∂ϕT
]
.
We can estimate the standard error of the parameters by inverting the approximated
observed information matrix and taking square root of the diagonal elements. Then, approx-
imate confidence intervals can be constructed using the asymptotic normality of maximum
likelihood estimates.
5.4 Probabilistic inference of variant-specific causal effects
To gain a better picture of our knowledge of each individual SNP, we can sample from
P (βi, Zi, θXi |θˆXi , θˆYi , ϕˆ)—the posterior distribution of variant-specific latent variables given
an MC-EM estimate of ϕ—by using the sampling/importance resampling (SIR) algorithm
(Li, 2004). For example, P (Zi = k|θˆXi , θˆYi , ϕˆ)—the cluster membership probability of the
ith SNP—quantifies how certain we are that the ith SNP belongs to a certain cluster. More
specifically, suppose we have M samples {βji , Zji , θjXi : j = 1, . . . ,M} from our importance
distribution for the ith SNP. Then we can obtain samples of βi from P (βi|θˆXi , θˆYi , ϕˆ) by
sampling—with replacement—from {βji } with probabilities proportional to the importance
weights given in eq. (16). Samples from P (Zi|θˆXi , θˆYi , ϕˆ) and P (θXi |θˆXi , θˆYi , ϕˆ) can be ob-
tained in a similar fashion. In particular, these samples can be used to construct credible
intervals of βi and compute cluster membership probabilities—see section 7 for examples.
5.5 Model Selection
To select the number of clusters K, we use a modified Bayesian Information criterion (BIC)
for latent variable models estimated using the EM algorithm adopted from Ibrahim et al.
(2008). For MR-PATH, the standard BIC is typically defined as
BIC = −2 logP (D|ϕˆ) + (3K + 2p) log(p)
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where ϕ is the MLE of ϕ and 3K + 2p is the dimension of our model. We replace the
marginal density P (D|ϕˆ) with the readily available IS estimate of the Q-function at the final
MC-EM iteration from eq. (17).
6 Simulation study
To verify the efficacy of our statistical inference procedures, we perform two simulation stud-
ies. The goal of the first simulation study is to demonstrate that (1) the MC-EM algorithm
gives parameter estimates that are close to the ground truth and (2) the approximate con-
fidence intervals we derive have desirable coverage probabilities. The goal of our second
simulation study is to evaluate the accuracy of the modified BIC for selecting the number of
clusters K.
6.1 Parameter Estimation & Confidence Intervals
In our first simulation study, we generate simulated data from MR-PATH under various
parameter settings that mimic GWAS summary data used in practice. In each setting, we
generate measurement errors as σ2Xi , σ
2
Yi
∼ Inv. Gamma(9, .0002). This is a reasonable choice
as modern GWAS are conducted with large sample sizes which result in low measurement
errors. Moreover, we set the instrument strength parameter to be λx = 10/
√
p. We set λx
to be inversely related to the number of genetic variants p because a larger p corresponds
to a less stringent criterion for filtering the genetic variants. We vary the number of genetic
variants to be p = 50, 100, 500, 1000 and the number of clusters to be Ktrue = 1, 2, 3. In MR,
we do not expect the number of clusters to be greater than 3 and the number of filtered
genetic variants to be large. For each parameter setting, we ran the MC-EM algorithm with
K = Ktrue and computed the approximated confidence intervals with 500 simulated data-
sets and calculated the root mean squared error (RMSE) and 95% coverage probability. As
the EM algorithm is sensitive to initial value specification, for each repetition, we run the
MC-EM algorithm 10 times with different random initial values and report the results from
the run with the largest complete-data log likelihood. Simulation results are presented in
Figure 4. Note that as K increases, we choose mixture means to be closer in value, making
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the estimation task more challenging.
In this simulation study, the RMSE for each scenario does not exceed .09 and the coverage
probability for most scenarios do not deviate much from the desired 95%. Furthermore,
we observe a trade-off between RMSE and coverage probability when filtering out weaker
instruments (variants with θˆXi ≈ 0). Keeping more weaker instruments (larger p) results in
lower RMSE but coverage probabilities that deviate more from 95%.
µ σ
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(a) K = 1. µ1 = 0.3, σ1 = 0.1
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(b) K = 2. pi1 = 0.5, µ1 = −0.5, µ2 = 0.5, and σ1 = σ2 = 0.1
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(c) K = 3. pi1 = pi3 = 0.3, µ1 = −0.5, µ2 = 0, µ3 = 0.5, and σ1 = σ2 = σ3 = 0.1
Figure 4: Results from first simulation study. For each parameter setting, we simulated
Nrep = 500 data-sets. Each row corresponds to a different number of cluster K with the
ground truth in the sub-captions. Each plot corresponds to one of the mixture parameters
pi = (pi1, . . . , piK), µ = (µ1, . . . , µK), σ = (σ1, . . . , σK) in MR-PATH. Left: Plots of root mean
squared error (RMSE) against the number of variants p for each mixture parameter. Right:
Plots of 95% coverage probabilities against p for each mixture parameter. A horizontal
dashed line is drawn at .95 (desired coverage prob.).
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6.2 Model Selection with modified BIC
In our second simulation study, we simulate data from MR-PATH with p = 50 or 250 and
√
pλx = 1 or 5. In each setting, we set the true number of clusters Ktrue = 1,2, or 3. In each
replication, we ran the MC-EM algorithm with K = 1, 2, 3 and chose the K that yields the
lowest modified BIC value. Results for this simulation study are shown in table 2.
From table 2, we observe that lower values for
√
pλx result in the largest decreases in
the accuracy of the modified BIC. For example, when p = 50 and Ktrue = 2, the modified
BIC chose the correct K 92% of the time when
√
pλx = 5 but only 71% of the time when
√
pλx = 1. We also notice that when
√
pλx = 1, the accuracy of the modified BIC decreases
with p. A practical consequence of this observation is that the modified BIC is more likely
to choose the correct K with few strong instruments than with more weak instruments.
7 Real data applications
7.1 Results for the motivating HDL-CHD example
We now return to the motivating example introduced in Section 1.1. The dataset being
used is created from several large-scale GWAS datasets for plasma lipids (HDL-C, LDL-C,
triglycerides) (Teslovich et al., 2010; Willer et al., 2013), coronary heart disease (Nikpay
et al., 2015), lipoprotein subfractions (Kettunen et al., 2016), and other cardiovascular dis-
eases. We use the three-sample summary-data MR design described in Zhao et al. (2020)
to preprocess and homogeneize the datasets. We first select 151 independent SNPs (dis-
tance ≥ 10 mega base pairs, R2 ≤ 0.001 in a reference panel) that are associated with at
least plasma lipid traits (defined as the minimum p-value with HDL-C, LDL-C, and triglyc-
erides less than 10−4). We then obtain the GWAS associations of these SNPS with all the
other cardiometabolic traits. For the purpose of this example, we will focus on 31 SNPs
that showed genome-wide significant associations (p-value ≤ 5 × 10−8) with HDL-C in the
selection GWAS.
We apply the Monte Carlo EM algorithm developed in Section 5 to the 31 genetic in-
struments and their associations with HDL-C in a separate dataset (Kettunen et al., 2016)
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Proportion
p
√
pλx Ktrue K = 1 K = 2 K = 3
50
1
1 .83 .17 0
2 0 0.71 0.29
3 0 .01 0.99
5
1 .98 0.02 0
2 0 0.92 0.08
3 0 .002 .998
250
1
1 .76 0.24 0
2 0 0.67 0.33
3 0 .005 .995
5
1 1 0 0
2 0 0.99 0.01
3 0 0 1
Table 2: Results from second simulation study. For each setting, we simulated Nrep = 500
data-sets. For Ktrue = 1, we set µ1 = 0.5 and σ1 = 0.1. For Ktrue = 2, we set pi1 = 0.5,
µ = (−0.5, 0.5), and σ1 = σ2 = 0.1. For Ktrue = 3, we set pi1 = pi2 = 1/3, µ = (−0.5, 0, 0.5),
and σ1 = σ2 = σ3 = 0.05. The last column reports the proportion of repetitions for each
setting where the modified BIC chose the corresponding K.
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and CHD. The modified BIC selects K = 2 clusters of SNPs. The larger cluster (pˆi1 = 0.82)
corresponds to a negative effect (µˆ1 = −0.343, σˆ1 = 0.23) and the smaller cluster (pˆi2 = 0.18)
corresponds to a positive effect (µˆ2 = 0.14, σˆ2 = 0.09). The SNPs are classified into the two
clusters based on their posterior probabilities (Section 5.4). Figure 1b shows the scatterplot
of the HDL-CAD data with the MC-EM parameter estimates. Figure 5 shows the posterior
estimates of the variant-specific βj along side the cluster membership probabilities.
To validate the mechanistic heterogeneity identified by MR-PATH, we generate a heatmap
of the associations (z-scores) of the SNPs with lipoprotein subfraction traits (Kettunen et al.,
2016). Most of the traits are named after their size (XS = extra small, S = small, M =
medium, L = large, XL = extra large, XXL = double extra large), their lipoprotein class
(HDL, IDL = intermediate-density lipoprotein, LDL, VLDL = very-low-density lipoprotein),
and the measurement (C = total cholesterol, CE = cholesterol esters, FC = free cholesterol,
L = total lipid, P = particle concentration, PL = phosolipids, TG = triglycerides). Other
traits including the mean diameter of HDL/LDL/VLDL particles (HDL-D/LDL-D/VLDL-
D) and the concentration of ApoA1/ApoB (major protein component of HDL/LDL). To
aid visualization, the SNPs are ordered by their cluster membership probabilities and the
lipoprotein subfractions are ordered by their density and size.
The heatmap in Figure 6 shows that the SNP clusters found by the mixture model exhibit
different patterns of association with the lipoprotein subfractions. Several SNPs in the first
cluster have strong inverse association with LDL-C and other LDL/VLDL subfraction traits.
Therefore, the negative effect of HDL-C on CHD sugested by the instruments in the first
cluster cluster may indeed be due to their pleiotropic effect on LDL-C and ApoB-containing
lipoproteins (see scenario 1 in Figure 3a). In contrast, several SNPs in the second cluster
(rs1532085, rs588136, rs174546, rs7679) are inversely associated with the concentration of
small HDL particles, so they may be related to another mechanism that regulates the size of
HDL particles. Although the instruments in this cluster suggest a positive effect of HDL-C
on CHD, this may be explained by heterogeneous effects of cholesterol contained in different
HDL subfractions (see scenario 2 in Figure 3a). An earlier univariable MR study indeed found
that the concentration of small and medium HDL particles may have a negative effect on
CHD, while the large and extra large HDL particles seem to have no effect (Zhao et al., 2019).
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Figure 5: SNP-specific posterior quantities in HDL-CAD data. The SNPs are ordered by
their posterior probability of belonging to cluster 2. Top: 95% posterior credible intervals.
Colored dashed lines are the estimated cluster means and x-marks are the posterior medians
for each SNP. Bottom: Posterior cluster membership probabilities bar plot. Vertical axis is
posterior probability of belonging to cluster 2.
To summarize, the heatmap provides some evidence that the clustering structure identified
by our mixture model indeed corresponds to some distinct underlying mechanisms.
7.2 The role of adiposity in type II diabetes
We now turn to a second example to illustrate the utility of MR-PATH. In this example, we
are interested in possible mechanistic heterogeneity of the effect of adiposity (as measured
by the body mass index, BMI) on type II diabetes (T2D). Following the same three-sample
summary-data MR design as describe in Section 7.1, we created a dataset of 60 SNPs from
two GWAS summary datasets for BMI (Akiyama et al., 2017; Locke et al., 2015) and one
for T2D (Mahajan et al., 2018). We then apply the Monte Carlo EM algorithm developed in
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Section 5. The modified BIC selects K = 2 clusters of SNPs. The larger cluster (pˆi2 = 0.88)
corresponds to a positive effect (µˆ1 = 0.77, σˆ2 = 0.42) and the smaller cluster (pˆi1 = 0.12)
corresponds to a very large negative effect (µˆ1 = −12.4, σˆ1 = 1.8). See Figure 7 for the
scatterplot of the data with the estimated mixture model parameters.
We did a GWAS catalog (Buniello et al., 2019) search for the SNPs belonging to cluster 2
and found that several of them are related to insulin function which tightly regulates glucose
level and plays a crucial role in diabetes. This motivated us to compare the estimate variant-
specific effect βˆi with the SNP association with peak blood insulin, which is available from
an independent GWAS (Wood et al., 2017) (Figure 9). In fact, six out of the seven SNPs
classified into cluster 2 are strongly associated with peak blood insulin. This shows that the
large negative effect of this cluster is most likely due to horizontal pleiotropy (Figure 3a)
instead of a genuine negative causal effect of adiposity. The results we obatined here are
broadly consistent with other recent genetic studies that have identified SNPs with opposite
effects on adiposity and type II diabetes and linked the “favorable adiposity” genes to insulin
function and fat distribution (Ji et al., 2019).
8 Discussion
In this paper, we have formalized the notion of mechanistic heterogeneity in the context of
MR and showed that SNPs on the same biological pathway identify similar causal effects.
Different pathways generally correspond to different causal effects, even if they are all valid
instruments. Motivated by this observation, we introduced MR-PATH, an interpretable
mixture model for from summary-level GWAS data that can provide valuable insights on
mechanistic heterogenity.
MR-PATH has several advantages over similar existing methods for MR. First, it relaxes
the effect homogeneity assumption implicit in most existing MR methods so it is able to
identify multiple causal mechanisms. Second, MR-PATH does not require substantial domain
knowledge since we use a data-driven approach to select the number of clusters. Lastly, MR-
PATH is based on a full likelihood and is robust to weak instrument bias since we use an
error-in-variables approach to estimate the variant-specific causal effects. We showed using
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numerical simulations that our MC-EM algorithm gives parameter estimates that are close
to the ground truth and the corresponding approximate confidence intervals have coverage
probabilities close to their true values. We also showed that the modified BIC criterion we
used for selecting the number of clusters chose correctly most of the time.
We demonstrated the utility of MR-PATH in modeling mechanistic heterogeneity in
MR analysis by using it to investigate the causal mechanisms between HDL-C and CHD
and between adioposity and type II diabetes. These examples reinforce the importance of
considering multiple causal mechanisms in MR analysis. Our findings are consistent with
existing genetic studies that use external data. For the HDL-C and CHD data set, MR-
PATH identifies a cluster with a positive average causal effect which may be associated with
a mechanism that regulates size of HDL particles. In our study of the role of adioposity on
type II diabetes, MR-PATH finds a cluster with a negative average causal effect that is likely
attributed to horizontal pleiotropy.
Since MR-PATH is a generative model for multiple causal mechanisms in MR, there are
many potential extensions that can be incorporated in future work. One such extension is
to replace our univariate mixture model with a multivariate model to consider multiple risk
exposures simultaneously. The multivariate version of MR-PATH can be used to account
for the pleiotropic effects of other lipoproteins in our HDL and CHD example. Another
possible extension is to allow for correlated SNPs by relaxing the independence assumption
in assumption 4.1.
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A Technical Appendix
A.1 Bounded Importance Sampling weights
Following eq. (13), the importance weights are given by
wji =
P (θXi |θˆXi , θˆYi , ϕ)
P (θXi |θˆXi , ϕ)
∝ P (θXi |θˆXi , ϕ)P (θˆYi |θXi , ϕ)
=
K∑
k=1
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2piθ2Xiσ
2
k + σ
2
Yi
exp
{
− 1
2(θ2Xiσ
2
k + σ
2
Yi
)
(Yi − θXiµk)2
}
≤ 1√
2piσ2Yi
,
for i = 1, . . . , p; j = 1, . . . ,M . Therefore, the importance weights are bounded and have
a finite variance.
A.2 Importance sampling estimate of η2
An importance sampling estimate of η2 at iteration t in eq. (22) is given by
ηˆ2 = mt
p∑
i=1
{ mt∑
j=1
wjiΛ
(t)
ij
}2[∑mt
j=1(w
j
iΛ
(t)
ij )
2
(
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ij )
2
− 2
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j
i )
2Λ
(t)
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j
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(t)
ij
+
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(wji )
2
]
,
where Λ
(t)
ij is given in eq. (21).
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Figure 6: A heatmap showing the z-scores of the SNPs’ associations with lipoprotein sub-
fraction measurements. The SNPs are ordered by their posterior probability of belonging to
cluster 2 as in Figure 5. The lipoprotein subfractions are ordered by their density and size.
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Figure 7: Scatterplot of BMI-T2D data with MC-EM parameter estimates. The colored
lines/shaded regions represent the estimated cluster means ± 1 estimated standard deviation
(i.e. µˆk ± σˆk). The points are colored according to the cluster with the highest posterior
cluster membership probability P (Zi = k|θˆXi , θˆYi).
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Figure 8: SNP-specific posterior quantities in BMI-T2D data. SNPs are ordered by their
posterior probability of belonging to cluster 2. Top: 95% posterior credible intervals. Col-
ored dashed lines are the estimated cluster means (same as Figure 7) and x-marks are the
posterior medians for each SNP. Bottom: Posterior cluster membership probabilities bar
plot. Vertical axis is posterior probability of belonging to cluster 2.
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Figure 9: Relationship of SNP-specific slope and the association with peak blood insulin. The
horizontal axis is the posterior median of the SNP-specific slope βi with standard error bars.
The vertical axis is the SNP association with peak blood insulin with standard error bars
reported in an independent GWAS. The SNPs are colored according to the cluster with the
highest posterior cluster membership probability P (Zi = k|θˆXi , θˆYi).
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